Diagnostic Radioisotope Market Report: Trends, Forecast and Competitive Analysis to 2030
2 – 3 business days after placing order
Diagnostic Radioisotope Trends and Forecast
The future of the global diagnostic radioisotope market looks promising with opportunities in the hospital, specialty clinic, diagnostic center, and academic & research institute markets. The global diagnostic radioisotope market is expected to reach an estimated $6.4 billion by 2030 with a CAGR of 6.7% from 2024 to 2030. The major drivers for this market are increasing demand for early and accurate diagnosis of diseases, growing advancements in diagnostics imaging modalities, and expanding demand for alpha radioisotopes.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Diagnostic Radioisotope by Segment
The study includes a forecast for the global diagnostic radioisotope by radioisotope, imaging modality, application, end use, and region.
Diagnostic Radioisotope Market by Radioisotope [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies diagnostic radioisotope companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the diagnostic radioisotope companies profiled in this report include-
Lucintel forecasts that technetium-99m is expected to witness the highest growth over the forecast period.
Within this market, specialty clinic is expected to witness the highest growth over the forecast period.
North America will remain the largest region over the forecast period.
Features of the Global Diagnostic Radioisotope Market
Market Size Estimates: Diagnostic radioisotope market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Diagnostic radioisotope market size by various segments, such as by radioisotope, imaging modality, application, end use, and region in terms of value ($B).
Regional Analysis: Diagnostic radioisotope market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different radioisotopes, imaging modalities, applications, end uses, and regions for the diagnostic radioisotope market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the diagnostic radioisotope market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the diagnostic radioisotope market size?
Answer: The global diagnostic radioisotope market is expected to reach an estimated $6.4 billion by 2030.
Q2. What is the growth forecast for diagnostic radioisotope market?
Answer: The global diagnostic radioisotope market is expected to grow with a CAGR of 6.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the diagnostic radioisotope market?
Answer: The major drivers for this market are increasing demand for early and accurate diagnosis of diseases, growing advancements in diagnostics imaging modalities, and expanding demand for alpha radioisotopes.
Q4. What are the major segments for diagnostic radioisotope market?
Answer: The future of the diagnostic radioisotope market looks promising with opportunities in the hospital, specialty clinic, diagnostic center, and academic & research institute markets.
Q5. Who are the key diagnostic radioisotope market companies?
Answer: Some of the key diagnostic radioisotope companies are as follows:
Answer: Lucintel forecasts that technetium-99m is expected to witness the highest growth over the forecast period.
Q7. In diagnostic radioisotope market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the diagnostic radioisotope market by radioisotope (technetium-99m, thallium-201, gallium-67, iodine-123, FDG, rubidium-82, and others), imaging modality (SPECT, PET, and beta emitters), application (diagnostic and therapeutic), end use (hospitals, specialty clinics, diagnostic centers, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Diagnostic Radioisotope Market, Diagnostic Radioisotope Market Size, Diagnostic Radioisotope Market Growth, Diagnostic Radioisotope Market Analysis, Diagnostic Radioisotope Market Report, Diagnostic Radioisotope Market Share, Diagnostic Radioisotope Market Trends, Diagnostic Radioisotope Market Forecast, Diagnostic Radioisotope Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Diagnostic Radioisotope Trends and Forecast
The future of the global diagnostic radioisotope market looks promising with opportunities in the hospital, specialty clinic, diagnostic center, and academic & research institute markets. The global diagnostic radioisotope market is expected to reach an estimated $6.4 billion by 2030 with a CAGR of 6.7% from 2024 to 2030. The major drivers for this market are increasing demand for early and accurate diagnosis of diseases, growing advancements in diagnostics imaging modalities, and expanding demand for alpha radioisotopes.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Diagnostic Radioisotope by Segment
The study includes a forecast for the global diagnostic radioisotope by radioisotope, imaging modality, application, end use, and region.
Diagnostic Radioisotope Market by Radioisotope [Shipment Analysis by Value from 2018 to 2030]:
- Technetium-99m
- Thallium-201
- Gallium-67
- Iodine-123
- FDG
- Rubidium-82
- Others
- SPECT
- PET
- Beta Emitters
- Diagnostic
- Therapeutic
- Hospitals
- Specialty Clinics
- Diagnostic Centers
- Academic & Research Institutes
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies diagnostic radioisotope companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the diagnostic radioisotope companies profiled in this report include-
- GE Healthcare
- Siemens Healthineers
- Koninklijke Philips
- Cardinal Health
- Lantheus Holdings
- Bayer
- Bracco
- Eckert & Ziegler
- Nordion
- NTP Radioisotopes
Lucintel forecasts that technetium-99m is expected to witness the highest growth over the forecast period.
Within this market, specialty clinic is expected to witness the highest growth over the forecast period.
North America will remain the largest region over the forecast period.
Features of the Global Diagnostic Radioisotope Market
Market Size Estimates: Diagnostic radioisotope market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Diagnostic radioisotope market size by various segments, such as by radioisotope, imaging modality, application, end use, and region in terms of value ($B).
Regional Analysis: Diagnostic radioisotope market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different radioisotopes, imaging modalities, applications, end uses, and regions for the diagnostic radioisotope market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the diagnostic radioisotope market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the diagnostic radioisotope market size?
Answer: The global diagnostic radioisotope market is expected to reach an estimated $6.4 billion by 2030.
Q2. What is the growth forecast for diagnostic radioisotope market?
Answer: The global diagnostic radioisotope market is expected to grow with a CAGR of 6.7% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the diagnostic radioisotope market?
Answer: The major drivers for this market are increasing demand for early and accurate diagnosis of diseases, growing advancements in diagnostics imaging modalities, and expanding demand for alpha radioisotopes.
Q4. What are the major segments for diagnostic radioisotope market?
Answer: The future of the diagnostic radioisotope market looks promising with opportunities in the hospital, specialty clinic, diagnostic center, and academic & research institute markets.
Q5. Who are the key diagnostic radioisotope market companies?
Answer: Some of the key diagnostic radioisotope companies are as follows:
- GE Healthcare
- Siemens Healthineers
- Koninklijke Philips
- Cardinal Health
- Lantheus Holdings
- Bayer
- Bracco
- Eckert & Ziegler
- Nordion
- NTP Radioisotopes
Answer: Lucintel forecasts that technetium-99m is expected to witness the highest growth over the forecast period.
Q7. In diagnostic radioisotope market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the diagnostic radioisotope market by radioisotope (technetium-99m, thallium-201, gallium-67, iodine-123, FDG, rubidium-82, and others), imaging modality (SPECT, PET, and beta emitters), application (diagnostic and therapeutic), end use (hospitals, specialty clinics, diagnostic centers, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Diagnostic Radioisotope Market, Diagnostic Radioisotope Market Size, Diagnostic Radioisotope Market Growth, Diagnostic Radioisotope Market Analysis, Diagnostic Radioisotope Market Report, Diagnostic Radioisotope Market Share, Diagnostic Radioisotope Market Trends, Diagnostic Radioisotope Market Forecast, Diagnostic Radioisotope Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL DIAGNOSTIC RADIOISOTOPE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Diagnostic Radioisotope Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Diagnostic Radioisotope Market by Radioisotope
3.3.1: Technetium-99m
3.3.2: Thallium-201
3.3.3: Gallium-67
3.3.4: Iodine-123
3.3.5: FDG
3.3.6: Rubidium-82
3.3.7: Others
3.4: Global Diagnostic Radioisotope Market by Imaging Modality
3.4.1: SPECT
3.4.2: PET
3.4.3: Beta Emitters
3.5: Global Diagnostic Radioisotope Market by Application
3.5.1: Diagnostic
3.5.2: Therapeutic
3.6: Global Diagnostic Radioisotope Market by End Use
3.6.1: Hospitals
3.6.2: Specialty Clinics
3.6.3: Diagnostic Centers
3.6.4: Academic & Research Institutes
3.6.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Diagnostic Radioisotope Market by Region
4.2: North American Diagnostic Radioisotope Market
4.2.1: North American Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.2.2: North American Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.3: European Diagnostic Radioisotope Market
4.3.1: European Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.3.2: European Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.4: APAC Diagnostic Radioisotope Market
4.4.1: APAC Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.4.2: APAC Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.5: ROW Diagnostic Radioisotope Market
4.5.1: ROW Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.5.2: ROW Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Diagnostic Radioisotope Market by Radioisotope
6.1.2: Growth Opportunities for the Global Diagnostic Radioisotope Market by Imaging Modality
6.1.3: Growth Opportunities for the Global Diagnostic Radioisotope Market by Application
6.1.4: Growth Opportunities for the Global Diagnostic Radioisotope Market by End Use
6.1.5: Growth Opportunities for the Global Diagnostic Radioisotope Market by Region
6.2: Emerging Trends in the Global Diagnostic Radioisotope Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Diagnostic Radioisotope Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diagnostic Radioisotope Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: GE Healthcare
7.2: Siemens Healthineers
7.3: Koninklijke Philips
7.4: Cardinal Health
7.5: Lantheus Holdings
7.6: Bayer
7.7: Bracco
7.8: Eckert & Ziegler
7.9: Nordion
7.10: NTP Radioisotopes
2. GLOBAL DIAGNOSTIC RADIOISOTOPE MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Diagnostic Radioisotope Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Diagnostic Radioisotope Market by Radioisotope
3.3.1: Technetium-99m
3.3.2: Thallium-201
3.3.3: Gallium-67
3.3.4: Iodine-123
3.3.5: FDG
3.3.6: Rubidium-82
3.3.7: Others
3.4: Global Diagnostic Radioisotope Market by Imaging Modality
3.4.1: SPECT
3.4.2: PET
3.4.3: Beta Emitters
3.5: Global Diagnostic Radioisotope Market by Application
3.5.1: Diagnostic
3.5.2: Therapeutic
3.6: Global Diagnostic Radioisotope Market by End Use
3.6.1: Hospitals
3.6.2: Specialty Clinics
3.6.3: Diagnostic Centers
3.6.4: Academic & Research Institutes
3.6.5: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Diagnostic Radioisotope Market by Region
4.2: North American Diagnostic Radioisotope Market
4.2.1: North American Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.2.2: North American Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.3: European Diagnostic Radioisotope Market
4.3.1: European Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.3.2: European Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.4: APAC Diagnostic Radioisotope Market
4.4.1: APAC Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.4.2: APAC Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
4.5: ROW Diagnostic Radioisotope Market
4.5.1: ROW Diagnostic Radioisotope Market by Radioisotope: Technetium-99m, Thallium-201, Gallium-67, Iodine-123, FDG, Rubidium-82, and Others
4.5.2: ROW Diagnostic Radioisotope Market by End Use: Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Diagnostic Radioisotope Market by Radioisotope
6.1.2: Growth Opportunities for the Global Diagnostic Radioisotope Market by Imaging Modality
6.1.3: Growth Opportunities for the Global Diagnostic Radioisotope Market by Application
6.1.4: Growth Opportunities for the Global Diagnostic Radioisotope Market by End Use
6.1.5: Growth Opportunities for the Global Diagnostic Radioisotope Market by Region
6.2: Emerging Trends in the Global Diagnostic Radioisotope Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Diagnostic Radioisotope Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Diagnostic Radioisotope Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: GE Healthcare
7.2: Siemens Healthineers
7.3: Koninklijke Philips
7.4: Cardinal Health
7.5: Lantheus Holdings
7.6: Bayer
7.7: Bracco
7.8: Eckert & Ziegler
7.9: Nordion
7.10: NTP Radioisotopes
